AngioWaveNet vs Zio ECG Utilization Software (ZEUS) System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AngioWave
VS
by iRhythm Technologies

AI Verdict

AngioWaveNet and the Zio ECG Utilization Software (ZEUS) System are adjacent AI tools within cardiology, both leveraging AI to enhance cardiac care. AngioWaveNet focuses on improving vessel visualization in fluoroscopic angiograms for interventional procedures, integrating with existing cath lab workflows. In contrast, ZEUS analyzes continuous ECG data from wearable monitors to aid in the diagnosis and management of cardiac arrhythmias, primarily for remote monitoring applications.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary need is to enhance the clarity and detail of fluoroscopic angiograms during or immediately after cardiac catheterization or interventional radiology procedures. This tool is ideal for improving real-time vessel visualization and anatomical feature identification within existing cath lab workflows, regardless of your current angiography system vendor.

View AngioWaveNet →

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if you require a comprehensive, AI-powered solution for long-term, continuous ECG monitoring to diagnose and manage cardiac arrhythmias. This cloud-based platform is best suited for identifying intermittent or sustained arrhythmias over an extended period (up to 14 days) using wearable Zio monitors, providing detailed reports for remote patient assessment.

View Zio ECG Utilization Software (ZEUS) System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet Zio ECG Utilization Software (ZEUS) System
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Unknown
Deployment Cloud-based or on-premise/servers Cloud-based.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet emphasizes seamless integration into existing Cath lab workflows, offering vendor-agnostic compatibility and functioning as a DICOM endpoint. It boasts 'No Cart, No Hardware, No Downtime' and requires minimal training for clinicians, suggesting a smoother and less disruptive adoption process.

Clinical Value

Zio ECG Utilization Software (ZEUS) System

The Zio ECG Utilization Software (ZEUS) System has demonstrated extensive clinical value through multiple real-world studies (e.g., AVALON, CAMELOT), showing superior diagnostic yield, faster time to diagnosis, and lower retesting rates for cardiac arrhythmias. Its AI algorithm is clinically proven to perform at the level of cardiologists. AngioWaveNet, while valuable for image enhancement, has less publicly available extensive clinical validation beyond case reports.

Pricing & Value

AngioWaveNet

AngioWaveNet offers more transparent pricing options, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs. This flexibility and upfront clarity provide a better basis for assessing value compared to ZEUS, which only states 'contact for pricing' with no public details.

Enterprise Readiness

AngioWaveNet

Both tools are FDA-cleared and HIPAA compliant, crucial for enterprise adoption. However, AngioWaveNet offers both cloud-based and on-premise deployment options, providing greater flexibility for institutions with varying IT infrastructure and data security requirements. Its vendor-agnostic compatibility with existing angiography systems further enhances its readiness for diverse hospital environments.

Innovation

Zio ECG Utilization Software (ZEUS) System

The Zio ECG Utilization Software (ZEUS) System represents a more significant innovation by combining AI-powered analytics with a novel wearable biosensor for continuous, long-term cardiac monitoring. This approach offers a new paradigm for arrhythmia diagnosis and management. AngioWaveNet's deep-learning based image enhancement is innovative within its domain but is an improvement on existing imaging rather than a new diagnostic modality.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

iRhythm Technologies provides comprehensive support resources for the ZEUS System, including dedicated customer care via phone and email, along with extensive online documentation such as Instructions for Use, Clinical Reference Manuals, and detailed FAQs. AngioWaveNet mentions onboarding support and training but offers less specific information regarding ongoing customer support channels.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet Zio ECG Utilization Software (ZEUS) System
Name AngioWaveNet Zio ECG Utilization Software (ZEUS) System
Company Angiowave Imaging iRhythm Technologies
Primary Function AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Interventional Radiology, Vascular Surgery Cardiology, Family Medicine, Internal Medicine
Integration/Compatibility Integrates with existing Cath lab workflows; compatible with any fluoroscopic angiography system (vendor-agnostic); functions as a DICOM endpoint. Integration with Zio wearable biosensors (Zio monitor, Zio Watch); HL7-based EHR integration.

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and Zio ECG Utilization Software (ZEUS) System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is FDA-cleared AI software designed to enhance fluoroscopic angiograms, improving vessel visualization in cardiac catheterization laboratories for interventional procedures. In contrast, the Zio ECG Utilization Software (ZEUS) System is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
AngioWaveNet integrates with existing Cath lab workflows, is compatible with any fluoroscopic angiography system (vendor-agnostic), and functions as a DICOM endpoint for imaging systems. The ZEUS System integrates with Zio wearable biosensors and offers HL7-based EHR integration, with data accessible via the ZioSuite web portal and mobile application for healthcare professionals.
AngioWaveNet performs post-processing AI on angiographic images to enhance the visibility of blood vessels, vascular structures, and anatomical features from fluoroscopic angiograms. The ZEUS System analyzes continuous ECG data collected from Zio wearable monitors for arrhythmia detection and classification.
AngioWaveNet is designed for Cardiology, Interventional Radiology, and Vascular Surgery, focusing on enhancing visualization during angiographic procedures. The ZEUS System is applicable to Cardiology, Family Medicine, and Internal Medicine, aiding in the diagnosis and management of cardiac arrhythmias.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.